|1.||Gelb, Michael H: 11 articles (10/2015 - 10/2004)|
|2.||Murakami, Makoto: 10 articles (10/2015 - 11/2007)|
|3.||Lambeau, Gérard: 10 articles (10/2015 - 01/2008)|
|4.||Yang, Chuen-Mao: 9 articles (06/2015 - 06/2009)|
|5.||Nevalainen, T J: 9 articles (01/2010 - 01/2000)|
|6.||Gattaz, Wagner F: 8 articles (10/2015 - 05/2003)|
|7.||Yamamoto, Kei: 7 articles (10/2015 - 11/2008)|
|8.||Farooqui, Akhlaq A: 6 articles (12/2015 - 11/2004)|
|9.||Taketomi, Yoshitaka: 6 articles (10/2015 - 11/2008)|
|10.||Liu, Nai-Kui: 6 articles (05/2014 - 04/2006)|
10/18/1990 - "Inhibitors of phospholipase A2 might therefore act to reduce the effects of inflammation, so structural information about the binding of phospholipase A2 to its substrates could be helpful in the design of therapeutic drugs. "
12/01/1995 - "Based on the fact that during inflammation several cell types synthesize and secrete a group II phospholipase A2 (PLA2), an immunohistochemical study was undertaken to explore whether this enzyme can be identified in human atherosclerotic lesions. "
10/02/2014 - "Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation."
12/15/2013 - "Here, we analyze the role of human group IIA secreted phospholipase A2 (sPLA2-IIA), a bactericidal enzyme induced during acute inflammation, in innate immunity against GBS. "
10/15/2013 - "Various events including digestion and inflammation are regulated by secreted phospholipase A2 (sPLA2) in gastrointestinal tissues, however, the role of sPLA2 on contractile activity has not been elucidated. "
|2.||Septic Shock (Toxic Shock Syndrome)
11/01/1986 - "Potential therapeutic efficacy of inhibitors of human phospholipase A2 in septic shock."
11/01/1991 - "A predictive model for the clearance of soluble phospholipase A2 during septic shock."
01/01/1999 - "Subcellular membrane impairment and application of phospholipase A2 inhibitors in endotoxic shock."
03/01/1995 - "Endotoxin or cytokine-induced expression of a secretory non-pancreatic phospholipase A2 (sPLA2) has been implicated in the pathogenesis of multisystem organ dysfunction or failure in patients with septic shock. "
09/01/1993 - "1. An increase in circulating levels of extracellular group II phospholipase A2 (PLA2) has been detected in patients with septic shock as well as in rats, rabbits and human volunteers following intravenous endotoxin administration. "
02/01/2000 - "Role of various phospholipases A2 and inhibitors in the pathogenesis and prevention of pancreatic acinar cell necrosis: studies with isolated rat pancreatic acini."
01/01/2014 - "ExoU, which exhibits phospholipase A2 activity activated by host cell ubiquitination after translocation, is a major pathogenic cytotoxin that causes alveolar epithelial injury and macrophage necrosis. "
09/01/2003 - "Distinct regulation of cytosolic phospholipase A2 phosphorylation, translocation, proteolysis and activation by tumour necrosis factor-receptor subtypes."
02/01/2000 - "Phospholipase A2 (PLA2) may play a central role in the pathogenesis of pancreatic acinar cell necrosis. "
02/01/1999 - "Finally, addition of tumour necrosis factor alpha to H9c2 cells resulted in an elevation of both phosphatidylglycerolphosphate synthase and phospholipase A2 activities. "
01/01/1999 - "The study aims at elucidating the mechanism involved in the cell dysfunction or impairment and the protective effects of phospholipase A2 (PLA2) inhibitors in endotoxin shock. "
06/01/1990 - "The current study assessed the ability of cold shock (5 degrees C) and phospholipase A2 (PA2) to duplicate these effects on membrane structure and to affect 45Ca2+ uptake and gross morphological characteristics of whole, fresh boar-sperm. "
11/01/2013 - "Phospholipase A2 (PLA(2)) is a key enzyme for the production of lipid mediators in posthemorrhagic shock mesenteric lymph (PHSML). "
10/01/2001 - "Role of gut flora on intestinal group II phospholipase A2 activity and intestinal injury in shock."
10/29/1990 - "Enhanced expression of group II phospholipase A2 gene in the tissues of endotoxin shock rats and its suppression by glucocorticoid."
08/01/1987 - "Improved method for the determination of phospholipase A2 catalytic activity concentration in human serum and ascites."
01/01/1990 - "Similarly, intravenously-administered ascites and intraperitoneal instillation of pancreatic phospholipase A2 dissolved in saline were without effects. "
01/01/1990 - "Phospholipase A2 activity of ascites was 40 U/microL 1 h after the induction of AEP and decreased during the next 3 h gradually to a plateau of about 20 U/microL, where it remained to the end of the experiment at 24 h. "
04/01/1993 - "In conclusion, the present study confirmed the presence of pancreatic phospholipase A2 in human duodenal juice and in the ascites of necrotizing pancreatitis. "
01/01/1990 - "The aim of the study was to elucidate the role of the pancreatitis ascites and its phospholipase A2 activity on the observed peritoneal permeability increase during AEP. "
|2.||Interleukin-1 (Interleukin 1)
|4.||Arachidonic Acid (Vitamin F)
|6.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|7.||Nitric Oxide (Nitrogen Monoxide)